AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 23620931
Drug: Balance needling
RxNorm normalized name: Rebalance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Balance needling therapy
Trial: 21148517
Drug: Telavancin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telavancin (10 mg/kg every 24 h)
Trial: 18093662
Drug: Carbamazepine (CBZ)
RxNorm normalized name: Carbamazepine
DrugBank: Carbamazepine (DB00564)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Carbamazepine (CBZ) 300-800 mg/daily (mean final dose 461.6 mg/day)
Trial: 12898007
Drug: Gemfibrozil 600
RxNorm normalized name: gemfibrozil 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemfibrozil 600 mg orally twice daily for 4 days
Trial: 10725065
Drug: Neoral (microemulsion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoral (microemulsion formulation of cyclosporin A)
Trial: 10725065
Drug: Sandimmun (original
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sandimmun (original formulation of cyclosporin A)
Trial: 2438997
Drug: Novel oral
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Novel oral rehydration mixture based on fruit juice cordial
Trial: 29626933
Drug: Nutrition Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nutrition Therapy with RDN to develop an individualized eating plan (Group A)
Trial: 29626933
Drug: Nutrition Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nutrition Therapy with RDN and a structured meal plan (Group B)
Trial: 29626933
Drug: Nutrition Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nutrition Therapy with RDN, a structured meal plan, and weekly phone support (Group C)
Trial: 18312763
Drug: Simvastatin 20
RxNorm normalized name: simvastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin 20 mg and Fenofibrate 160 mg (Combination therapy)
Trial: 16768549
Drug: Polychromatic light
RxNorm normalized name: kaolin light
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polychromatic light (480-3400 nm) at a therapeutic dose of 12 J/cm²
Trial: 11149164
Drug: Photocoagulation laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Photocoagulation laser therapy
Trial: 11149164
Drug: Prompt diagnosis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prompt diagnosis and treatment for endophthalmitis and mucormycosis
Trial: 11149164
Drug: Emergent ophthalmologic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Emergent ophthalmologic evaluation and treatment for herpes zoster infection
Trial: 8731519
Drug: 0.3 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3 mg/kg DMT fumarate
Trial: 19577308
Drug: SRI treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SRI treatment (clomipramine, fluvoxamine, or fluoxetine)
Trial: 9010690
Drug: ketoprofen 3
RxNorm normalized name: ketoprofen 320 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ketoprofen 3 x 25 mg per day
Trial: 9010690
Drug: ketoprofen 3
RxNorm normalized name: ketoprofen 320 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ketoprofen 3 x 50 mg per day
Trial: 9010690
Drug: ibuprofen 3
RxNorm normalized name: ibuprofen 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ibuprofen 3 x 200 mg per day
Trial: 9010690
Drug: ibuprofen 3
RxNorm normalized name: ibuprofen 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ibuprofen 3 x 400 mg per day
Trial: 1504643
Drug: Intravenous fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous fentanyl (50 micrograms/70 kg)
Trial: 6421508
Drug: Sodium cromoglycate
RxNorm normalized name: Sodium cromoglycate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium cromoglycate (SCG) 2 g/l
Trial: 6421508
Drug: Sodium cromoglycate
RxNorm normalized name: Sodium cromoglycate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium cromoglycate (SCG) 20 g/l
Trial: 6421508
Drug: Sodium cromoglycate
RxNorm normalized name: Sodium cromoglycate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium cromoglycate (SCG) 40 g/l
Trial: 31443961
Drug: Adjuvant docetaxel
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adjuvant docetaxel 75 mg/m2 every 3 weeks for 6 cycles (arm A)
Trial: 18928633
Drug: Glucocorticoid treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucocorticoid treatment (n = 35)
Trial: 18928633
Drug: Anti-HP treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-HP treatment (n = 30)
Trial: 18928633
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment (glucocorticoid + HP eradication, n = 35)
Trial: 10512960
Drug: Implant-supported overdenture
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Implant-supported overdenture (IOD)
Trial: 7796075
Drug: Dietary therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dietary therapy
Trial: 28495389
Drug: Antibiotics scenario
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotics scenario
Trial: 28495389
Drug: Vaccine-hesitancy scenario
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaccine-hesitancy scenario
Trial: 15185877
Drug: Active drug
RxNorm normalized name: Capillary active drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active drug (ranitidine, 150 mg b.d.)
Trial: 9701194
Drug: Short-chain fructans
RxNorm normalized name: Medium-Chain Triglycerides
DrugBank: Medium-chain triglycerides (DB13959)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short-chain fructans (10-30 g)
Trial: 9701194
Drug: Long-chain fructans
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long-chain fructans (10-30 g)
Trial: 7977881
Drug: Fluphenazine decanoate
RxNorm normalized name: Fluphenazine Decanoate
DrugBank: Fluphenazine (DB00623)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluphenazine decanoate reduced-dose group (average 11.5 mg every 2 weeks)
Trial: 7977881
Drug: Fluphenazine decanoate
RxNorm normalized name: Fluphenazine Decanoate
DrugBank: Fluphenazine (DB00623)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluphenazine decanoate control group (23 mg every 2 weeks)
Trial: 1071665
Drug: Phentolamine administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phentolamine administration
Trial: 27552500
Drug: Indomethacin 0.1%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin 0.1% 3 times daily for 1 week
Trial: 27552500
Drug: Dexamethasone 0.1%
RxNorm normalized name: DEXAMETHASONE 0.1% GEL,TOP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 0.1% 3 times daily for 1 week
Trial: 27552500
Drug: No anti-inflammatory
RxNorm normalized name: Surpass Anti-Inflammatory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No anti-inflammatory treatment
Trial: 22123802
Drug: Antibiotics (omeprazole,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotics (omeprazole, amoxicillin trihydrate, and clarithromycin) for 10 days
Trial: 15257176
Drug: rilmenidine 1
RxNorm normalized name: rilmenidine 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rilmenidine 1 mg twice daily
Trial: 7997386
Drug: Intravenous fructose‐1,6‐diphosphate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous fructose‐1,6‐diphosphate 125 mg/kg
Trial: 7997386
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline 1.3 ml/kg
Trial: 20087376
Drug: Multivitamins and
RxNorm normalized name: multivitamins and iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multivitamins and 7 mg Zinc daily for 10 weeks
Trial: 18174214
Drug: Dexamethasone (Dex:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (Dex: 2 x 2 mg per day)
Trial: 10326325
Drug: Ferrous sulphate
RxNorm normalized name: Ferrous sulphate
DrugBank: Ferrous fumarate (DB14491)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ferrous sulphate tablets containing 60 mg of elemental iron
Trial: 10326325
Drug: Ferrous sulphate
RxNorm normalized name: Ferrous sulphate
DrugBank: Ferrous fumarate (DB14491)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ferrous sulphate tablets containing 120 mg of elemental iron
Trial: 10326325
Drug: Ferrous sulphate
RxNorm normalized name: Ferrous sulphate
DrugBank: Ferrous fumarate (DB14491)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ferrous sulphate tablets containing 180 mg of elemental iron
Trial: 10326325
Drug: Ferrous fumarate
RxNorm normalized name: Ferrous Fumarate
DrugBank: Ferrous fumarate (DB14491)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ferrous fumarate syrup
Trial: 10326325
Drug: Gelatin capsules
RxNorm normalized name: Gelatin Capsules
DrugBank: Gelatin (DB11242)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gelatin capsules containing pure ferrous salt
Trial: 10326325
Drug: Ferrous fumarate
RxNorm normalized name: Ferrous Fumarate
DrugBank: Ferrous fumarate (DB14491)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ferrous fumarate tablets
Trial: 10326325
Drug: Powdered ferrous
RxNorm normalized name: ferrous sulfate Topical Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Powdered ferrous sulphate tablets
Trial: 10326325
Drug: Iron tablets
RxNorm normalized name: Iron 65 MG Oral Tablet [LEADER IRON TABLETS]
DrugBank: Iron (DB01592)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Iron tablets distributed by the NNAPP
Trial: 8622045
Drug: Third-generation chemotherapy
RxNorm normalized name: regenerated cellulose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Third-generation chemotherapy regimens (F-MACHOP or MACOP-B)
Trial: 1933116
Drug: Textured surface
RxNorm normalized name: hepatitis B surface antigen vaccine Injection [Recombivax]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Textured surface silicone implants
Trial: 1933116
Drug: Smooth surface
RxNorm normalized name: Derma-Smoothe FS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Smooth surface silicone implants
Trial: 7310012
Drug: Lodoxamide tromethamine
RxNorm normalized name: Lodoxamide Tromethamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lodoxamide tromethamine (0.1 mg in saline)
Trial: 30192638
Drug: Mepolizumab (750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mepolizumab (750 mg intravenously)
Trial: 28064380
Drug: Admission albumin
RxNorm normalized name: Albumin Aggregated
DrugBank: Albumin Aggregated (DB14230)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Admission albumin < 30 g/L
Trial: 19335534
Drug: Sulfonylurea (SU)
RxNorm normalized name: sulfanilylurea
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulfonylurea (SU) or combination of SU/metformin (Met)/thiazolidinediones (TZD)
Trial: 19335534
Drug: Metformin (Met)/Thiazolidinediones
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (Met)/Thiazolidinediones (TZD)
Trial: 17991260
Drug: Rectal diclofenac
RxNorm normalized name: diclofenac Rectal Suppository
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rectal diclofenac 1 mg.kg(‐1)
Trial: 17991260
Drug: Paracetamol 40
RxNorm normalized name: Hydrocodone bitartrate 5 mg and paracetamol 400 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol 40 mg.kg(‐1)
Trial: 17991260
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of rectal diclofenac and paracetamol
Trial: 9481597
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg sibutramine
Trial: 9481597
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg sibutramine
Trial: 9481597
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg and 15 mg sibutramine
Trial: 2515494
Drug: Oral zinc
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral zinc acetate (6-month study)
Trial: 2515494
Drug: Oral pergolide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral pergolide mesylate (3-month crossover study)
Trial: 31735650
Drug: We Immunize
RxNorm normalized name: Immune Globulin
DrugBank: Human immunoglobulin G (DB00028)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: We Immunize program (2-hour enhanced training and tailored monthly feedback for 6 months)
Trial: 18813910
Drug: Respiratory physiotherapy
RxNorm normalized name: tissue respiratory factor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Respiratory physiotherapy (six treatments: positioning, manual hyperinflation, and suctioning in each 24-hour period while on mechanical ventilation)
Trial: 17503315
Drug: Octreotide 30
RxNorm normalized name: octreotide 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Octreotide 30 mg monthly alone
Trial: 17503315
Drug: Octreotide 30
RxNorm normalized name: octreotide 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Octreotide 30 mg monthly in combination with rofecoxib (up to 50 mg bid daily)
Trial: 15066461
Drug: 0.625 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.625 mg/day of CEE and calcium
Trial: 11806623
Drug: roxithromycin tablets
RxNorm normalized name: roxithromycin
DrugBank: Roxithromycin (DB00778)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: roxithromycin tablets 300 mg once a day (Rx)
Trial: 11806623
Drug: amoxicillin/clavulanic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: amoxicillin/clavulanic acid tablets 875+125 mg twice a day (Acx)
Trial: 25931293
Drug: Needle aspiration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Needle aspiration and antibiotics
Trial: 17312647
Drug: Injection sclerotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection sclerotherapy (IS)
Trial: 30974049
Drug: Pooled data
RxNorm normalized name: NO DATA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pooled data of Revefenacin 88 μg and 175 μg
Trial: 25523285
Drug: antipsychotics
RxNorm normalized name: ANTIPSYCHOTICS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: antipsychotics
Trial: 24790178
Drug: Simvastatin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin (20 mg) plus ezetimibe (10 mg) daily
Trial: 22534815
Drug: Bortezomib 1.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bortezomib 1.8 mg/m weekly on day 1 and day 8, carboplatin AUC 6, and bevacizumab 15 mg/kg every 3 weeks.
Trial: 22534815
Drug: Bortezomib 1.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bortezomib 1.8 mg/m weekly on day 1 and day 8, carboplatin AUC 6, and bevacizumab 15 mg/kg every 3 weeks (phase II portion).
Trial: 22534815
Drug: Treatment related
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment related grade-3/4 toxicities.
Trial: 17179250
Drug: Transdermal scopolamine
RxNorm normalized name: Transderm Scop
DrugBank: Scopolamine (DB00747)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal scopolamine (TDS) 1.5 mg
Trial: 17179250
Drug: Droperidol 1.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Droperidol 1.25 mg IV
Trial: 15049459
Drug: DEC 6
RxNorm normalized name: Zodryl DEC 60 Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DEC 6 mg/kg + ALB placebo
Trial: 11493282
Drug: Reviparin at
RxNorm normalized name: reviparin
DrugBank: Reviparin (DB09259)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reviparin at a dose of 85 IU anti‐Xa/kg
Trial: 11493282
Drug: Nadroparin at
RxNorm normalized name: nadroparin
DrugBank: Nadroparin (DB08813)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nadroparin at a standard dose of 70 IU anti‐Xa/kg
Trial: 9489907
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg omeprazole and 150 mg TAP
Trial: 24188203
Drug: Nebulized high-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulized high-dose budesonide (BUD group)
Trial: 17113722
Drug: Oral sodium
RxNorm normalized name: Oral Film
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral sodium phosphate (NaP)
Trial: 21979395
Drug: Oral sodium
RxNorm normalized name: Oral Film
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral sodium phosphate (NaP) plus alverine citrate
Trial: 18466681
Drug: T-614 25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: T-614 25 mg daily
Trial: 18466681
Drug: T-614 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: T-614 50 mg daily
Trial: 2938923
Drug: Floxuridine infusions
RxNorm normalized name: Floxuridine
DrugBank: Floxuridine (DB00322)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Floxuridine infusions into the hepatic artery using a totally implantable pump system (Infusaid, model 400)
Trial: 31735618
Drug: Flibanserin 100
RxNorm normalized name: flibanserin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flibanserin 100 mg + ethanol 0.6 g/kg
Trial: 31735618
Drug: Flibanserin 100
RxNorm normalized name: flibanserin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flibanserin 100 mg + ethanol 0.4 g/kg
Trial: 31735618
Drug: Flibanserin 100
RxNorm normalized name: flibanserin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flibanserin 100 mg + ethanol 0.2 g/kg
Trial: 31735618
Drug: Flibanserin 100
RxNorm normalized name: flibanserin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flibanserin 100 mg only
Trial: 31735618
Drug: Flibanserin 100
RxNorm normalized name: flibanserin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flibanserin 100 mg with ethanol (0.2-0.6 g/kg)
Trial: 31735618
Drug: Flibanserin 100
RxNorm normalized name: flibanserin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flibanserin 100 mg + ethanol (0.4 g/kg and 0.6 g/kg)
Trial: 31735618
Drug: Flibanserin 100
RxNorm normalized name: flibanserin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flibanserin 100 mg + ethanol
Trial: 1709335
Drug: Chomelanum (preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chomelanum (preparation A)
Trial: 1709335
Drug: Lasonil (preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lasonil (preparation B)
Trial: 1709335
Drug: Ointment base
RxNorm normalized name: Ointment base
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ointment base of Chomelanum (preparation C)
Trial: 22258291
Drug: Inhaled sevoflurane
RxNorm normalized name: sevoflurane Inhalation Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled sevoflurane
Trial: 20708349
Drug: Regular prescription
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular prescription of BZD
Trial: 12814272
Drug: Standard Treatment
RxNorm normalized name: Azo-Standard
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Standard Treatment (ST) plus Motivational Interviewing
Trial: 6155131
Drug: Pseudoephedrine 120
RxNorm normalized name: CTM 8/PSEUDOEPHEDRINE 120MG SA CAP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pseudoephedrine 120 mg
Trial: 1804647
Drug: Terfenadine-pseudoephedrine combination
RxNorm normalized name: pseudoephedrine / terfenadine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terfenadine-pseudoephedrine combination
Trial: 6391829
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg meptazinol 4-times daily
Trial: 6391829
Drug: 65 mg
RxNorm normalized name: opium 65 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 65 mg dextropropoxyphene plus 650 mg paracetamol 4-times daily
Trial: 26085822
Drug: N-3 supplementation
RxNorm normalized name: 22:6(n-3)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: N-3 supplementation (5 ml seal oil, 375 mg EPA, 230 mg DPA, 510 mg DHA)
Trial: 26085822
Drug: Placebo (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (5 ml olive oil)
Trial: 17882582
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (conventional organ preservation treatment)
Trial: 14997188
Drug: Hormonal therapy
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormonal therapy with radiotherapy
Trial: 10975783
Drug: Two-week dual
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two-week dual therapy (lansoprazole 30 mg plus amoxycillin 1 g bid for two weeks)
Trial: 10975783
Drug: One-week triple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: One-week triple therapy (lansoprazole 30 mg plus amoxycillin 1 g plus tinidazole 500 mg bid for one week plus lansoprazole qd for an additional week)
Trial: 10975783
Drug: Triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple therapy (after one year follow-up)
Trial: 10975783
Drug: Dual therapy
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual therapy (after one year follow-up)
Trial: 1592541
Drug: 350 mg
RxNorm normalized name: hemin 350 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 350 mg oral sustained release theophylline twice a day
Trial: 22445423
Drug: Active model
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active model group (n=176) with self-evaluation kit and treatment of metronidazole 500 mg twice daily for 7 days
Trial: 14623548
Drug: Aromatase inhibitors
RxNorm normalized name: Aromatase inhibitors
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aromatase inhibitors (exemestane, anastrozole)
Trial: 14623548
Drug: Combination strategies
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination strategies of gonadotrophin agonists and aromatase inhibitors